The escalating cost of developing drugs is due, in part, to time spent assessing compounds that fail further down the drug discovery process. As such, high-content analysis (HCA) is now emerging as ...

Larry Sklar (left) is a Distinguished Professor Emeritus at the University of New Mexico (UNM; NM, USA) whose interest in flow cytometry as a tool for drug discovery led to the development of ...

How do we “name” a cell and assign its identity? How do we know that we are all talking about the same cells? How do we agree on what it takes to confidently correlate previous with current research ...

Flow cytometry is an invaluable method for biomedical research. Since its development over 50 years ago, technology for flow cytometry has progressed rapidly, allowing for the detection of more and ...

Over the past decade, the genomics revolution has encouraged scientists to perform target-based drug discovery. However, among new first-in-class drugs that have emerged in recent years, over 60% have ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) has announced the NovoCyte Opteon Spectral Flow Cytometer, propelling flow cytometry into a new era of and accessibility. This ...

Immunologists typically employ several in vitro techniques to analyze immune system cells, including flow cytometry, polymerase chain reaction (PCR) tests, and various enzyme-linked immunosorbent ...

Setting up reliable controls is one of the priorities that any scientist should be concerned with when engaging in scientific research and experimentation. Without controls, it is nearly impossible to ...

Antibody-drug conjugates (ADCs) represent a powerful therapeutic modality for solid tumors and hematological malignancies. However, their development is often challenged by limited translational ...